Trial site
Halifax
Halifax, Nova Scotia B3H 1V7, CanadaNot linked to an institution yet
- 7running trials
- 4closed trials
The trials here
What the 11 trials at this site are about, from their registry records.
- Phase
- Phase 1/25 trials
- Phase 35 trials
- Phase 11 trial
- Status
- Active, not recruiting6 trials
- Completed4 trials
- Recruiting1 trial
Running trials
Active, not recruiting
A Study of Belrestotug Plus Dostarlimab Compared With Placebo Plus Pembrolizumab in Previously Untreated Participants With Programmed Death Ligand 1 (PD-L1) High Non-small-cell Lung Cancer (NSCLC)
NCT06472076· Phase 3· GlaxoSmithKline· Source
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
NCT05855200· Phase 3· GlaxoSmithKline· Source
Contact: Katerina Neumann (principal investigator)
Active, not recruiting
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Nirogacestat, Pomalidomide, and Dexamethasone in Participants With RRMM
NCT07150104· Phase 1/2· GlaxoSmithKline· Source
Active, not recruiting
A Study on the Long-term Efficacy, Safety and Persistence of Immune Response of a Vaccine Against Herpes Zoster in Older Adults
NCT05371080· Phase 3· GlaxoSmithKline· Source
Active, not recruiting
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat, Lenalidomide, and Dexamethasone in Participants With RRMM
NCT07150091· Phase 1/2· GlaxoSmithKline· Source
Active, not recruiting
Sub-study of Belantamab Mafodotin (GSK2857916) in Combination With Nirogacestat in Participants With RRMM
NCT07084896· Phase 1/2· GlaxoSmithKline· Source
Active, not recruiting
Platform Study of Belantamab Mafodotin as Monotherapy and in Combination With Anti-cancer Treatments in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
NCT04126200· Phase 1/2· GlaxoSmithKline· Source
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error